The role of bone morphogenetic proteins in myeloma cell survival

Toril Holien1, Anders Sundan2

  • 1KG Jebsen Center for Myeloma Research, Department of Cancer Research and Molecular Medicine, NTNU, Faculty of Medicine, Norwegian University of Science and Technology, Postbox 8905, 7491 Trondheim, Norway.

Insights

Bone morphogenetic proteins (BMPs) are key in multiple myeloma, affecting tumor growth and bone health. Myeloma cells show sensitivity to BMPs, making them valuable for studying BMP signaling pathways.

Area of Science:

  • Hematology
  • Oncology
  • Bone Biology

Background:

  • Multiple myeloma involves malignant plasma cells in bone marrow, often causing osteolytic bone disease.
  • Bone morphogenetic proteins (BMPs) play roles in myeloma pathogenesis, including tumor cell growth, survival, bone homeostasis, and anemia.

Purpose of the Study:

  • To review and discuss current knowledge on Bone morphogenetic protein (BMP) signaling in multiple myeloma.
  • To highlight the significance of BMPs in myeloma pathogenesis and bone remodeling.

Main Methods:

  • Literature review of existing research on BMP signaling in multiple myeloma.
  • Analysis of studies focusing on BMP receptor usage and signaling pathways in myeloma cells.

Main Results:

  • Myeloma cells exhibit particular sensitivity to BMP-induced growth inhibition and apoptosis.
  • BMPs are implicated in myeloma pathogenesis, influencing tumor cell behavior and bone microenvironment.

Conclusions:

  • BMP signaling is a critical area for understanding multiple myeloma progression.
  • Myeloma cells serve as effective models for investigating BMP receptor function and downstream effects.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K